Intrathecal IgA synthesis in X-linked cerebral adrenoleukodystrophy

被引:14
作者
Korenke, GC [1 ]
Reiber, H [1 ]
Hunneman, DH [1 ]
Hanefeld, F [1 ]
机构
[1] UNIV GOTTINGEN,DEPT NEUROL,NEUROCHEM LAB,D-37075 GOTTINGEN,GERMANY
关键词
D O I
10.1177/088307389701200505
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cerebrospinal fluid data of 25 patients suffering from various phenotypes of X-linked adrenoleukodystrophy have been evaluated neurochemically including cerebrospinal fluid/serum quotient diagrams. Intrathecal IgA production in 13 of 14 patients with cerebral adrenoleukodystrophy was the most sensitive parameter in cerebrospinal fluid and was not seen in any of the neurologically asymptomatic patients or in the patients with adrenomyeloneuropathy. A blood-cerebrospinal fluid barrier dysfunction was found in 9 of these 14 patients. Additional intrathecal IgG or IgM synthesis was observed in 3 patients each. In 1 patient with lumbar punctures before and after onset of neurologic symptoms intrathecal IgA synthesis was seen only after the appearance of neurologic symptoms. Repetition of lumbar punctures in 5 neurologically symptomatic patients with cerebral adrenoleukodystrophy revealed a similar pattern of intrathecal IgA synthesis with a tendency to decreasing IgA concentration. The pathophysiologic aspects of intrathecal IgA synthesis are discussed in relation to other demyelinating and inflammatory neurologic diseases.
引用
收藏
页码:314 / 320
页数:7
相关论文
共 23 条
[1]   CEREBROSPINAL-FLUID IN THE DIAGNOSIS OF MULTIPLE-SCLEROSIS - A CONSENSUS REPORT [J].
ANDERSSON, M ;
ALVAREZCERMENO, J ;
BERNARDI, G ;
COGATO, I ;
FREDMAN, P ;
FREDERIKSEN, J ;
FREDRIKSON, S ;
GALLO, P ;
GRIMALDI, LM ;
GRONNING, M ;
KEIR, G ;
LAMERS, K ;
LINK, H ;
MAGALHAES, A ;
MASSARO, AR ;
OHMAN, S ;
REIBER, H ;
RONNBACK, L ;
SCHLUEP, M ;
SCHULLER, E ;
SINDIC, CJM ;
THOMPSON, EJ ;
TROJANO, M ;
WURSTER, U .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1994, 57 (08) :897-902
[2]   A 2-YEAR TRIAL OF OLEIC AND ERUCIC ACIDS (LORENZO OIL) AS TREATMENT FOR ADRENOMYELONEUROPATHY [J].
AUBOURG, P ;
ADAMSBAUM, C ;
LAVALLARDROUSSEAU, MC ;
ROCCHICCIOLI, F ;
CARTIER, N ;
JAMBAQUE, I ;
JAKOBEZAK, C ;
LEMAITRE, A ;
BOUREAU, F ;
WOLF, C ;
BOUGNERES, PF .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (11) :745-752
[3]   BRAIN-TISSUE IMMUNOGLOBULINS IN ADRENOLEUKODYSTROPHY - A COMPARISON WITH MULTIPLE-SCLEROSIS AND SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
BERNHEIMER, H ;
BUDKA, H ;
MULLER, P .
ACTA NEUROPATHOLOGICA, 1983, 59 (02) :95-102
[4]  
BRAUN A, 1995, AM J HUM GENET, V56, P854
[5]   THE DIAGNOSTIC-SIGNIFICANCE OF ANTIBODY SPECIFICITY INDEXES IN MULTIPLE-SCLEROSIS AND HERPES-VIRUS INDUCED DISEASES OF THE NERVOUS-SYSTEM [J].
FELGENHAUER, K ;
REIBER, H .
CLINICAL INVESTIGATOR, 1992, 70 (01) :28-37
[6]   MISSENSE MUTATIONS ARE FREQUENT IN THE GENE FOR X-CHROMOSOMAL ADRENOLEUKODYSTROPHY (ALD) [J].
FUCHS, S ;
SARDE, CO ;
WEDEMANN, H ;
SCHWINGER, E ;
MANDEL, JL ;
GAL, A .
HUMAN MOLECULAR GENETICS, 1994, 3 (10) :1903-1905
[7]  
Graef I T, 1994, Z Arztl Fortbild (Jena), V88, P587
[8]   IDENTIFICATION OF THE INFLAMMATORY CELLS IN THE CENTRAL-NERVOUS-SYSTEM OF PATIENTS WITH ADRENOLEUKODYSTROPHY [J].
GRIFFIN, DE ;
MOSER, HW ;
MENDOZA, Q ;
MOENCH, TR ;
OTOOLE, S ;
MOSER, AB .
ANNALS OF NEUROLOGY, 1985, 18 (06) :660-664
[9]  
HUNNEMAN DH, 1988, MONATSSCHR KINDERH, V136, P529
[10]   GLYCEROLTRIOLEATE GLYCEROLTRIERUCATE THERAPY IN 16 PATIENTS WITH X-CHROMOSOMAL ADRENOLEUKODYSTROPHY ADRENOMYELONEUROPATHY - EFFECT ON CLINICAL, BIOCHEMICAL AND NEUROPHYSIOLOGICAL PARAMETERS [J].
KORENKE, GC ;
HUNNEMAN, DH ;
KOHLER, J ;
STOCKLER, S ;
LANDMARK, K ;
HANEFELD, F .
EUROPEAN JOURNAL OF PEDIATRICS, 1995, 154 (01) :64-70